SA
FBRX icon

Sanctuary Advisors’s Forte Biosciences FBRX Stock Holding History

Sanctuary Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-881
Closed -$15.8K – 2538
2024
Q2 		$15.8K Buy
+881
New +$14.2K ﹤0.01% 2315

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sanctuary Advisors's FBRX Position: Q3 2024 in Review

Sanctuary Advisors sold out of Forte Biosciences (FBRX) in Q3 2024, closing a stake of 881 shares — an estimated $15.8K sold.

Sanctuary Advisors first reported a position in FBRX in Q2 2024 and held it in 1 quarter. The position peaked at $15.8K in Q2 2024. 24 funds tracked by Wall St. Rank hold FBRX as of Q3 2024.

  • Sanctuary Advisors reported no remaining Forte Biosciences position as of Q3 2024 after selling out during the quarter.
  • Sanctuary Advisors sold 881 Forte Biosciences shares in Q3 2024, an estimated $15.8K.
  • Sanctuary Advisors first reported a position in Forte Biosciences in Q2 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Forte Biosciences position peaked at $15.8K in Q2 2024.
  • 24 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2024.

Based on Sanctuary Advisors's 13F filing for Q3 2024, filed 25 Nov 2024.